The vendor opportunity at BlueSage Longevity Labs
BlueSage Longevity Labs operates a single company-owned unit in the health services sector, headquartered in Florida. The 2025 Franchise Disclosure Document does not disclose any franchised units, placing this system at a very early stage of franchise development. For software vendors, the immediate addressable market is exactly 1 location. The franchisor mandates a broad suite of operational and clinical technology, signaling a centralized approach to software procurement. While the total unit count is small, the depth of mandated systems suggests that any future franchisees will be required to adopt the same stack, creating a potential multiplier if the system expands.
Who controls software purchasing
The FDD lists Suzanne Sirota Rozenberg, D.O. as Chief Medical Officer. No other executives, such as a CIO, CTO, or VP of Operations, are named in the filing. In a single-unit, founder-led health services franchise, the CMO likely holds significant influence over technology decisions, particularly for clinical systems like the EMR and CRM/EMR. Vendors should prepare to engage a clinically oriented buyer who evaluates software through a patient-care and compliance lens. The absence of a dedicated IT leadership title suggests that purchasing authority is concentrated and informal.
Mandated and current tech stack
The 2025 FDD mandates five categories of technology: a CRM System, a CRM/EMR, an intranet and email system, an LMS and CRM system, and POS and EMR Software. The specific vendors for these mandated systems are not disclosed in the FDD. This stack covers the full operational spectrum—customer relationship management, electronic medical records, point-of-sale, learning management, and internal communications. For software vendors, the overlap between CRM and EMR mandates is notable; the franchisor may be using an integrated platform or separate best-of-breed solutions. The mandate structure means any vendor selling into this system must either displace an incumbent or fit into an unfilled niche within these broad categories.
Procurement, renewals, and timing
The FDD does not include an Item 8 extract, so the procurement model—whether designated supplier, approved supplier list, or open market—is not disclosed. The franchise agreement carries a 10-year initial term with a 6.0% royalty. Renewal requires notice between 12 and 24 months before expiration, a new agreement on then-current terms, a general release of claims, and payment of a renewal fee. With only one unit and no disclosed growth, software contract windows are tied to the initial term expiration or any decision to franchise additional units. Vendors should monitor for any expansion announcements that would trigger new technology deployments.
How to read the BlueSage Longevity Labs FDD
The 2025 FDD is embedded below for full review. Key sections for software vendors include Item 11 (the franchisor's obligations), which lists the mandated technology systems, and Item 17 (renewal and termination), which defines the contractual windows for change. Item 1 names the Chief Medical Officer as the sole executive on file, providing a starting point for outreach. Because the FDD does not disclose specific vendor names or an Item 8 procurement policy, vendors should use the document to confirm the mandated categories and then engage the HQ directly to understand the incumbent landscape. For a ranked target list of franchise systems matched to your software category, FranCloud can help.